BOSTON SCIENTIFIC CORPBSX

Market cap
$143.3B
P/E ratio
Dec 31,
2010
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Net income (loss)-1,065441-4,068-121-119-2393471041,6714,700-821,0416981,5921,846
Loss (gain) on disposal of businesses and assets-778153812----8-78-22--
Depreciation and amortization-7176836897257698158448941,0111,1231,0931,1361,1961,269
Deferred and prepaid income taxes-46-166-223-397-532-305245-87-4,301-82-124-63-1-70
Stock-based compensation expense150128108105103107116127140157170194220233266
Goodwill and other intangible asset impairment charges-2114253195191143510553337013258386
Net loss (gain) on investments and notes receivable-2737-927-9-21-92155-30398250-1-59-79
Contingent consideration net expense (benefit)------29-80-21-35-100-1363558-5
InventoryStepUpAmortization-----362210646583432651
Other, net-------------7374
Trade accounts receivable--42-37101-531721630110130-335279220238351
Inventories554-66781-3-401078329065346321660228
Other assets-1326068-91332325320172-45200134209-10126
Accounts payable, accrued expenses and other liabilities-1,148-271-131-37620-20553195-63111188408-255118243
Cash provided by (used for) operating activities3251,0081,2601,0821,2696009721,4263101,8361,5081,8701,5262,5033,435
Purchases of property, plant and equipment and internal use software272304226245259247376319316461376554588711790
Proceeds from sale of property, plant and equipment5161653--29-14712141243
Payments for acquisitions of businesses, net of cash acquired1993703662744861,7344085601,4484,38232,2581,5421,8114,640
Payments for investments and acquisitions of certain technologies------------2792489280
Proceeds from Divestiture of Businesses----------158265--
Proceeds from royalty rights6-5-9-5-14-61-----87-82-70-30-20
Proceeds from settlements of hedge contracts------------15-56-2-
Cash provided by (used for) investing activities-480769-579-475-745-2,186-887-1,010-1,921-5,041-411-1,597-2,011-2,574-5,687
Payment of contingent consideration previously established in purchase accounting----------491533539131
Payments for royalty rights----------9785755026
Payments for finance leases--------------25
Payments on short-term borrowings---------1,0002,950-250-504
Proceeds from Short-Term Debt--------9997002,245---24
Net increase (decrease) in commercial paper-------1,18321-575-714--1-4187
Payments on long-term borrowings and debt extinguishment costs----------1,260-3,184--
Proceeds from Issuance of Senior Long-Term Debt----------1,683-3,270-2,145
Cash dividends paid on preferred stock----------28555528-
Cash used to net share settle employee equity awards------626556655950535687
Proceeds from Stock Plans----------111110136182230
Cash provided by (used for) financing activities-496-1,721-744-596-1501,322-2061101,4322,973293-95-54851,814
Effect of foreign exchange rates on cash-----------2-6-9-4-11
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents----------1,388173-1,042-70-450
Income Taxes Paid-1389767748094---207302662512656
Cash paid for interest328--------449359338450259250
Fair value of contingent consideration recorded in purchase accounting--------248127-440-27329